can tirzepatide cause cancer and Thyroid Cancer: UK Evidence and Safety Guidance Does Tirzepatide Cause Cancer? |

In a large study of over 18,000 patients, rates of gastrointestinal side effects were similar between tirzepatide and semaglutide users, with no significant difference between the drugs

Not suggested

Providers communicate clearly, answer every question, and ensure there are no hidden costs

Cleavage Products of GLP-1 Moellmann et al

Tirzepatide is a once-weekly injectable medication that was initially developed to help manage blood sugar levels in people with type 2 diabetes

Novo expects to file for FDA approval in early 2026 , with potential launch in 2027, while Lillys retatrutide may reach the market slightly sooner